Post Market Surveillance Study Evaluating BioFoam Surgical Matrix in Cardiovascular Surgery

Inclusion Criteria: * Subject is undergoing an elective cardiac or cardiovascular procedure; * Subject is willing and able to give prior written informed consent for investigation participation; and * Subject is \> 18 years of age. Intraoperative inclusion criteria include: • Subject that requires the use of an adjunctive surgical hemostatic agent to the repair site to control generalized oozing following standard repair procedures (such as sutures and staples). Exclusion Criteria: * • Subject with known hypersensitivity to albumin, bovine products, or glutaraldehyde; * Subject with active infection (either systemic or in the repair region); * Subject whose pathology or underlying disease state makes them an unacceptable candidate for a clinical investigation in the opinion of the Investigator; * Subject diagnosed with a coagulation disorder; * Subject with abnormal calcium metabolism (e.g., chronic renal failure, hyperparathyroidism); * Subject whose life expectancy is less than that required for the prescribed follow-up duration; * Subject who is pregnant, planning on becoming pregnant during the follow-up period, or actively breast-feeding; or * Subject who is immunocompromised. Intraoperative exclusion criteria include: • Any major intraoperative bleeding incidences (i.e., American College of Surgeons Advanced Trauma Life Support Class II, III, or IV Hemorrhage).